Paul A Dagenais, PHD



Speech Pathology / Therapy   -  Alabama,  Mobile

 Overview

Paul A Dagenais, PHD works in Mobile, Alabama is a specialist in Speech Pathology / Therapy. 

 Specialties

  • Speech Pathology / Therapy

 State License

  • Alabama

 Education & Training

Education for Paul A Dagenais, PHD are not present.

 Awards

Awards for Paul A Dagenais, PHD are not present.

 Dr. Dagenais Reviews

Reviews for Paul A Dagenais, PHD are not present. Be the first to review this doctor!
 Add Review as registered PatientOR Add Review as Guest

 Office Locations


Primary location

 Office Address
2000 University Boulevard North
Alabama (AL)
Mobile
36618
 Phone:(251) 380-2600

Accepting New Patients

  • No
* Please verify this information when scheduling an appointment.

 Map & Directions



Office Address, 2000 University Boulevard North, Mobile, Alabama (AL), 36618




 Insurances Accepted (check insurance plans)

  • Blue Card PPO
  • Blue Cross Blue Shield
  • Choice Care PPO
  • First Health (Coventry Health Care)
  • First Health (Coventry Health Care) PPO
  • Humana
  • MultiPlan
  • MultiPlan PPO
  • PHCS Network PPO

* Please verify this information when scheduling an appointment.

 Blog Posts

Blog Posts for Paul A Dagenais, PHD are not present.

 Patients Questions

Patients questions for Paul A Dagenais, PHD are not present.

 Affiliated Hospitals

Affiliated hospitals for Paul A Dagenais, PHD are not present.

  •  Latest reviews for Speech Pathology / Therapy specialists

  • Dr. C. is a pleasant, professional caring and fun doctor. Answered all my questions on a keep it simple level and explained everything. He took his time. I will refer them when needed. What a great group!
    07 February 2024
    (6)
  • He is the best if you need help with panic attacks. He fixed up my medication and I feel better.
    31 January 2024
    (40)
  • Dr. Jungblut and staff are all professional, fun, conscientious. Been going here for a long time. My children and grandchildren now see Dr. Jungblut too.
    24 January 2024
    (7)
Close
Sign Up / Login
Connect with Sign Up / Login